Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018
January 02 2018 - 07:00AM
Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in
automated cell processing and point-of-care, autologous cell-based
therapies, today announced that Chris Xu, Ph.D., chief executive
officer, will be presenting at Biotech Showcase on Tuesday, January
9, 2018 at 4:00pm PST. The conference is being held January 8-10,
2018 at the Hilton San Francisco Union Square.
A live webcast of the presentation will be available
at:https://event.webcasts.com/starthere.jsp?ei=1176627&tp_key=d941414f85.
The webcast will be archived for 90 days.
About Cesca Therapeutics
Inc. Cesca is a leading regenerative medicine company
that develops, commercializes and markets a range of automated
technologies for cell-based therapeutics. Its device division,
ThermoGenesis, provides a full suite of solutions for automated
clinical biobanking, point-of-care applications, and automation for
immuno-oncology. Cesca is also leveraging its proprietary
AutoXpress® technology platform to develop an automated,
functionally-closed CAR-TXpress platform that addresses cellular
manufacturing needs in the immuno-oncology field.
Company Contact: Cesca Therapeutics Inc. Wendy
Samford916-858-5191ir@cescatherapeutics.com
Investor Contact: Rx CommunicationsPaula
Schwartz917-322-2216pschwartz@rxir.com
Cesca Therapeutics (NASDAQ:KOOL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cesca Therapeutics (NASDAQ:KOOL)
Historical Stock Chart
From Mar 2023 to Mar 2024